Influenza vaccine effectiveness to prevent medically attended laboratory confirmed influenza during season 2010-2011 in Romania: A case control study;Eficacitatea vaccinului gripal faţǎ de cazurile de gripǎ care s-au prezentat la medic în sezonul 2010-2011 în România: Studiu caz-martor

Revista Romana de Medicina de Laborator

Volumn 20, Issue 2-4, 2012, Pages 127-134

  Pitigoi, Daniela ^a,b   Ivanciuc, Alina Elena ^a   Necula, Gheorghe ^a   Lupulescu, Emilia ^a   Alexandrescu, Viorel ^a   Savulescu, Camelia ^b  

^a CANTACUZINO INSTITUTE   (Romania)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Case control; Influenza; Vaccine effectiveness

Indexed keywords

EID: 84864442493     PISSN: 18416624     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. World Health Organization. (2010) Recommended viruses for influenza vaccines for use in the 2010-2011 northern hemisphere influenza season. World Health Organization. Available from: http://www.who.int/influenza/vaccines/virus/recommendations/recommendations2010_11north/en/index.html
2. National Medicines Agency. Available from: http://www.anm.ro
3. European Centre for Disease Prevention and Control, European Influenza Surveillance Network (EISN). Available from: http://www.ecdc.europa.eu/en/activities/surveillance/EISN/Pages/index.aspx
4. National Institute of Public Health, Romania (Influenza, ARI and SARI surveillance methodology, 2010-2011). Available from: http://www.insp.gov.ro/cnscbt/index.phpoption=com_docman&task=cat_view&gid=41&Itemid=10 (accessed on 16/08/2011)
5. Kissling E, Valenciano M, Falcao J, Larrauri A, Widgren K, Pitigoi D et al. I-MOVE towards monitoring seasonal and pandemic influenza vaccine effectiveness: lessons learnt from a pilot multi-centric case-control study in Europe, 2008-9. Euro Surveill 2009;14(44): pii=19015388
6. Pitigoi D, Lupulescu E, Alexandrescu V, Baetel A, Sbarcea C, et al. (Efficiency of seasonal influenza vaccine in persons older than 65 in Romania. Pilot case-control study I-MOVE, 2008-2009) Bacteriol Virusol Parazitol Epidemiol 2009; 54: 109-16
7. Valenciano M, Kissling E, Cohen JM, Oroszi B, Barret AS, Rizzo C et al. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (IMOVE) multicentre case-control study. PLoS Med 2011 January; 8(1): e10000388. doi;10.1371/journal.pmed.1000388
8. Pitigoi D, Lupulescu E, Alexandrescu V, Baetel A, Sbarcea C, Savulescu C et al. Effectiveness of influenza pandemic vaccine - results of the IMOVE 2009-2010 study. Bacteriol Virusol Parazitol Epidemiol 2010; 55: 39-40
9. European Centre for Disease Prevention and Control (ECDC), Protocol for case-control studies to measure pandemic and seasonal influenza vaccine effectiveness in the European Union and European Economic Area Member States, Technical document. Available from: http://www.ecdc.europa.eu/en/publications/Publications/0907_TED_Influenza_AH1N1_Measuring_Influenza_Vaccine_Effectiveness_Protocol_Case_Control_Studies.pdf
10. European Commission. Commission Decision 2009/363/EC of 30 April 2009 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council, OJ L 110, 1.5.208, p. 58. Available on line:http://eur-lex.europa.eu/LexUriServ/LexUriServ.do? uri=OJ:L:2009:110:0058:0059:EN:PDF
11. Kissling E, Valenciano M, Cohen JM, Oroszi B, Barret A-S, Rizzo C, et al. I-MOVE Multi-Centre Case Control Study 2010-11: Overall and Stratified Estimates of Influenza Vaccine Effectiveness in Europe. PLoS ONE 2011; 6(11): e27622. doi:10.1371/journal.pone.0027622
12. Osterholm MT, Kelley KS, Sommer A, Belongia EA Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. LAncetID 2011; doi:10.1016/S1473-3099(11)70295-X
13. Pebody R, Hardelid P, Fleming D, McMenamin J, Andrews N, Robertson C et al. Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11. Euro. Surveill 16. Available from: http://www.eurosurveillance.org/images/dynamic/EE/V16N06/art19791.pdf
14. Savulescu C, Jimenez-Jorge S, de Mateo S, Ledesma J, Pozo F, Casas I, Larrauri A. (2011) Effectiveness of the 2010/11 seasonal trivalent influenza vaccine in Spain: preliminary results of a case-control study. Euro. Surveill 16. Available from: http://www.eurosurveillance.org/images/dynamic/EE/V16N11/art19820.pdf
15. Castilla J, Moran J, Martinez-Artola V, Reina G, Martinez-Baz I, Garcia CM, Alvarez N et al. Effectiveness of trivalent seasonal and monovalent influenza A(H1N1)2009 vaccines in population with major chronic conditions of Navarre, Spain: 2010/11 mid-season analysis. Euro. Surveill 16. Available: PM: 21345321
16. National Institute of Public Health, Romania; (Respiratory infections news, 16-22.05.2011); http://www.insp.gov.ro/cnscbt/index.php?option=com_docman&task=cat_view&gid=15&Itemid=13 (accessed at 16/08/2011)
17. Kilander A, Rykkvin R, Dudman S G, Hungnes O; Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009-2010, Euro Surveill. 2010;15(9): pii=19498. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19498
18. Valenciano M, Kissling E, Ciancio BC, Moren A. Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. Vaccine 2010; 28:7381-8. Available from: doi:10.1016/j.vaccine.2010.09.010